If we all are serious about the United States competing against and deterring China, we have to consider our vital defense infrastructure.
Susan Collins
The Public Record
Susan Margaret Collins is a United States Senator from Maine, serving since January 7, 1997. A member of the Republican Party, Collins is known for her moderate stance on various issues, often working across party lines. Throughout her tenure, she has focused on a range of topics including healthcare, national security, and economic policy. Collins has been recognized for her independent approach to governance, often emphasizing the importance of bipartisanship in her legislative efforts.
I am concerned, however, that the Administration is taking a very heavy-handed approach to achieving the goal of affordable housing.
There's no doubt that Americans are tired of our endless wars in Afghanistan.
I rise today to support the Shaheen- Collins substitute to prevent a cut in Medicare reimbursements for hospitals, nursing homes, home health agencies and other healthcare providers who continue to care for their patients in this era of…
I rise to urge my colleagues to support passage of H.R. 1799, the PPP Extension Act of 2021. It is imperative that we act immediately to pass this bill because we are just days away from the PPP being closed to applications for assistance…
I urge all of our colleagues to vote yes on this bill, which will provide a crucial 2-month extension for the Paycheck Protection Program. This program has been a lifeline to countless small businesses and has saved more than 50 million…
earlier this week, I joined Senator Leahy in introducing the Stop Illegal Trafficking in Firearms Act. Our bill would strengthen Federal law by making it easier for prosecutors to go after gun traffickers and straw purchasers, those…
small businesses and their employees are the backbone of our economy, particularly in States like those of the Presiding Officer and the State that I am privileged to represent, the great State of Maine. Later today, the Senate is slated…
Let me just say that I recognize this is a local and state decision, but the signals you send, the guidance you provide will be very influential.
I am concerned that San Diego, under your leadership, has closed its schools for in-person instruction this year.
the second bill I am introducing today is the Success for Rural Students and Communities Act. This bill would help students living in rural areas achieve their higher education goals and connect them with economic opportunities in their…
I ask unanimous consent that the order for the quorum call be rescinded. The PRESIDING OFFICER. Without objection, it is so ordered. (The remarks of Ms. Collins pertaining to the introduction of S. 883 and S. 885 are printed in today's…
helping students achieve their education and career goals has long been a priority for me. I come to the floor today to introduce two bipartisan bills. Both are aimed at helping students pursue higher education, complete their degrees, and…
Even though there are several biosimilars for the best-selling drug in the world, Humira, and they've been on the market in the European Union since 2018, American patients must wait another two years for them to be available here due to…
I led a bipartisan investigation with then-Senator Claire McCaskill of Missouri on sudden price spikes of off-patent drugs.
Let's bring this bill to the Senate floor as separate legislation so that we can have full and open debate and amendment to come up with the best solutions.
I also worked with Senator Bob Casey to investigate various entities in the opaque market for pricing of prescription drugs.
When a doctor prescribes a needed medication, an insurmountable barrier to taking it should not be its cost.
I think we're in the early innings of what will become an evolving set of tools that many innovator drug companies may engage with to protect their assets, and this runs completely counter to the objectives of competition for biosimilars…
As co-chairs of the Senate Diabetes Caucus, which I founded in 1998, Senator Jeanne Shaheen and I introduced legislation in the last Congress to create a new pricing model for insulin.
Later this spring, along with my colleague Senator Tim Kaine, I will reintroduce the Biologic Patent Transparency Act to prevent drug manufacturers from gaming the patent system.
How should Congress ensure that we are recognizing innovative science versus rewarding an innovative legal strategy that is simply designed to block more affordable competitors by gaming the patent system?
I rise today to join my colleague from Arizona, Senator Sinema, in introducing legislation to support the ongoing operation of the national child abuse hotline, which is currently operated by Childhelp, a national non-profit. Of all the…





